# Intraprostatic MAXimal Simultaneous Boost

> **NCT00798837** · NA · TERMINATED · sponsor: **British Columbia Cancer Agency** · enrollment: 10 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Intraprostatic maximal simultaneous boost

## Key facts

- **NCT ID:** NCT00798837
- **Lead sponsor:** British Columbia Cancer Agency
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-12
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Excess risk in rectal bleeding of first 10 patients
- **Last updated:** 2018-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00798837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00798837, "Intraprostatic MAXimal Simultaneous Boost". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00798837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*